糖心原创

”Patients first see their family medicine or primary care clinicians, and, all too often, the most complex lung diseases present in ways that are indistinguishable from more common conditions like asthma and COPD. Bringing together experts in both fields will yield the best results in creating a path to diagnosis.”

– William Lago, MD

”Delays in diagnosis of NTM disease and bronchiectasis cause irreparable respiratory damage and prolong patient suffering. We鈥檙e working to provide clinicians with the essential tools for earlier detection, accurate diagnosis, and effective management to help close care gaps and improve outcomes.”

– Doreen Addrizzo-Harris, MD, FCCP

”While interstitial lung diseases do not affect a substantial amount of the population, those touched by the disease are impacted tremendously. Any delay in receiving a diagnosis is time that could be dedicated to finding a treatment therapy that can improve their quality of life.”

– Andrew H. Limper, MD, FCCP

”Connecting patients to the correct diagnosis sooner decreases COPD symptom burden and improves their quality of life. It鈥檚 all about timely interventions that make a meaningful difference.”

– Megan Conroy, MD, MAEd, FCCP

”PH-ILD is a resource-intensive diagnosis. Not every clinician has access to specialized testing. These tools help bridge that gap, making it easier to identify PH-ILD and ensure patients receive a timely diagnosis and appropriate care.”

– Navneet Singh, MD, ScM

”Closing the gap in diagnosing ILDs like pulmonary fibrosis is critical so therapies can be initiated to manage the symptoms and progression of the disease.”

– Mary Beth Scholand, MD, FCCP